Global Multi Cancer Early Detection Market Size & Outlook
Global multi cancer early detection market, 2018-2030 (US$M)
Related Markets
Global multi cancer early detection market highlights
- The global multi cancer early detection market generated a revenue of USD 856.1 million in 2022 and is expected to reach USD 2,769.0 million by 2030.
- The market is expected to grow at a CAGR (2023 - 2030) of 15.8% by 2030.
- In terms of segment, gene panel, ldt & others accounted for a revenue of USD 849.4 million in 2022.
- Liquid Biopsy is the most lucrative type segment registering the fastest growth during the forecast period.
- In terms of region, Europe was the largest revenue generating market in 2022.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2023 to 2030.
Global data book summary
| Market revenue in 2022 | USD 856.1 million |
| Market revenue in 2030 | USD 2,769.0 million |
| Growth rate | 15.8% (CAGR from 2022 to 2030) |
| Largest segment | Gene panel, ldt & others |
| Fastest growing segment | Liquid Biopsy |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Liquid Biopsy, Gene Panel, LDT & Others |
Other key industry trends
- In terms of revenue, the North America accounted for 32.9% of the global multi cancer early detection market in 2022.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Saudi Arabia is the fastest growing regional market and is projected to reach USD 14.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Multi Cancer Early Detection Market Scope
Multi Cancer Early Detection Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global multi cancer early detection market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to multi cancer early detection market will help companies and investors design strategic landscapes.
Gene panel, ldt & others was the largest segment with a revenue share of 99.22% in 2022. Horizon Databook has segmented the Global multi cancer early detection market based on liquid biopsy, gene panel, ldt & others covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Multi Cancer Early Detection Type Outlook (Revenue, USD Million, 2018-2030)
- Liquid Biopsy
- Gene Panel, LDT & Others
- Global Multi Cancer Early Detection End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- Diagnostic Laboratories
- Others
Reasons to subscribe to Global multi cancer early detection market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global multi cancer early detection market databook
-
Our clientele includes a mix of multi cancer early detection market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global multi cancer early detection market , including forecasts for subscribers. This global databook contains high-level insights into Global multi cancer early detection market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global multi cancer early detection market size, by regions, 2018-2030 (US$M)
Top 10 countries: Multi cancer early detection market size, 2022 (US$M)
Global multi cancer early detection market share, by type, 2022 & 2030 (%, US$M)
Multi cancer early detection market: Opportunity assessment by country
Global multi cancer early detection market, by region, 2022 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
